Last 47 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Select Medical Holdings Corporation's quarterly P/E stands at 14.0x, up 27.8% year-over-year — indicating the stock has re-rated higher or earnings have softened. EV/EBITDA has compressed 32.2% YoY to 6.0x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 12.91 | 13.96 | 11.86 | 9.49 | — | 10.92 | 7.87 | 5.41 | 8.79 | 8.95 | 7.03 | 6.21 | 11.14 |
| — | +27.8% | +50.8% | +75.3% | — | +21.9% | +11.9% | -12.9% | -21.1% | -6.7% | -4.9% | -28.8% | +43.6% | |
| P/S Ratio | 0.34 | 0.29 | 0.35 | 0.39 | — | 0.33 | 0.46 | 0.28 | 0.32 | 0.25 | 0.31 | 0.26 | 0.27 |
| — | -12.5% | -23.4% | +38.5% | — | +31.9% | +45.3% | +9.7% | +19.7% | +8.7% | +25.4% | -1.7% | -18.3% | |
| P/B Ratio | 0.91 | 0.79 | 0.94 | 1.03 | 1.22 | 1.02 | 1.35 | 1.21 | 1.00 | 1.08 | 1.37 | 1.17 | 1.22 |
| — | -22.6% | -30.5% | -14.7% | +22.4% | -6.0% | -1.6% | +2.8% | -18.6% | +1.9% | +16.1% | -0.8% | -18.7% | |
| P/FCF | 4.84 | 3.24 | 10.26 | — | 9.82 | 4.49 | 2.63 | — | 3.30 | 6.35 | 3.00 | — | — |
| — | -27.8% | +290.6% | — | +197.8% | -29.2% | -12.4% | — | — | -8.6% | -5.3% | — | — | |
| EV / EBITDA | 20.26 | 5.95 | 9.67 | 8.20 | — | 8.78 | 14.15 | 7.08 | 15.10 | 9.08 | 8.43 | 8.34 | 12.15 |
| — | -32.2% | -31.6% | +15.8% | — | -3.3% | +67.9% | -15.0% | +24.3% | -18.6% | -10.8% | -20.5% | -6.7% | |
| EV / EBIT | 1805.91 | 7.45 | 11.72 | 9.66 | — | 10.29 | 21.56 | 8.60 | 20.10 | 13.06 | 10.39 | 11.22 | 18.05 |
| — | -27.6% | -45.6% | +12.4% | — | -21.2% | +107.6% | -23.4% | +11.3% | -18.4% | -18.8% | -24.5% | -2.0% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Select Medical Holdings Corporation's operating margin was 5.4% in Q3 2025, down 1.1 pp QoQ and down 2.7 pp YoY. This marks the 4th consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of 50.8% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 19.7% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 11.5% | 10.8% | 11.6% | 13.3% | 130.1% | 13.5% | 12.5% | 16.4% | 8.9% | 13.4% | 15.0% | 14.8% | 10.9% |
| — | -19.7% | -6.9% | -18.9% | +1359.8% | +0.6% | -16.8% | +11.2% | -18.4% | +20.7% | +22.3% | +22.8% | +8.3% | |
| Operating Margin | 0.0% | 5.4% | 6.5% | 8.3% | 183.2% | 8.0% | 5.8% | 10.8% | 5.3% | 7.8% | 9.5% | 9.1% | 5.5% |
| — | -33.2% | +12.1% | -23.2% | +3361.1% | +2.7% | -39.4% | +19.2% | -3.6% | +33.7% | +24.6% | +39.9% | +10.5% | |
| Net Margin | 2.7% | 2.1% | 3.0% | 4.2% | 13.1% | 3.2% | 6.1% | 5.4% | 3.8% | 2.9% | 4.7% | 4.3% | 1.7% |
| — | -33.1% | -50.0% | -22.7% | +244.7% | +9.2% | +29.5% | +27.4% | +118.4% | +66.9% | +34.1% | +38.5% | -45.6% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 7.3% | 1.4% | 2.0% | 2.8% | -0.7% | 2.8% | 4.6% | 6.0% | 3.0% | 3.1% | 5.2% | 5.0% | 2.0% |
| — | -47.9% | -56.0% | -53.1% | -125.2% | -11.7% | -12.9% | +20.1% | +48.5% | +56.0% | +30.6% | +40.6% | -32.9% | |
| ROA | 2.6% | 0.5% | 0.7% | 1.0% | -0.2% | 0.7% | 1.0% | 1.2% | 0.6% | 0.6% | 1.0% | 0.9% | 0.4% |
| — | -28.1% | -28.1% | -19.5% | -139.2% | +11.9% | -3.0% | +35.2% | +66.5% | +74.1% | +38.8% | +39.7% | -44.7% | |
| ROIC | 0.0% | 1.4% | 1.4% | 1.8% | -3.0% | 1.6% | 0.8% | 2.3% | 0.8% | 1.5% | 1.8% | 1.7% | 1.0% |
| — | -11.9% | +62.4% | -21.5% | -485.9% | +5.9% | -54.6% | +30.8% | -24.6% | +37.4% | +26.4% | +37.9% | +4.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Select Medical Holdings Corporation's Debt/EBITDA ratio is 9.6x, down from 23.7x last quarter — elevated, raising questions about debt serviceability.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.51 | 0.51 | 1.44 | 1.36 | 1.35 | 1.99 | 2.88 | 3.07 | 2.87 | 3.24 | 3.29 | 3.56 | 3.71 |
| — | -74.2% | -50.1% | -55.6% | -52.9% | -38.7% | -12.3% | -13.9% | -22.5% | -11.9% | -11.7% | +1.0% | +6.3% | |
| Debt / EBITDA | 7.39 | 9.61 | 23.70 | 18.88 | — | 23.89 | 39.15 | 20.59 | 45.26 | 27.54 | 24.13 | 25.39 | 37.07 |
| — | -59.8% | -39.5% | -8.3% | — | -13.3% | +62.2% | -18.9% | +22.1% | -21.7% | -17.1% | -20.8% | +0.8% | |
| Current Ratio | 1.04 | 1.09 | 1.15 | 1.16 | 1.04 | 1.13 | 1.09 | 1.22 | 1.01 | 1.09 | 1.10 | 1.11 | 1.10 |
| — | -3.7% | +6.0% | -4.9% | +3.5% | +3.0% | -1.1% | +9.8% | -8.5% | +7.6% | +11.6% | +5.3% | +23.0% | |
| Quick Ratio | 1.04 | 1.09 | 1.15 | 1.16 | 1.04 | 1.13 | 1.10 | 1.22 | 1.01 | 1.09 | 1.08 | 1.11 | 1.10 |
| — | -3.7% | +4.3% | -4.9% | +3.5% | +3.0% | +1.8% | +9.8% | -8.5% | +9.3% | +10.2% | +5.3% | +23.0% | |
| Interest Coverage | — | 2.44 | 2.89 | 3.88 | — | 2.55 | 1.99 | 3.82 | 1.27 | 2.59 | 3.25 | 3.12 | 1.83 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonSelect Medical Holdings Corporation's current P/E is 12.9x. The average P/E over the last 3 quarters is 11.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Select Medical Holdings Corporation's current operating margin is 0.0%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Select Medical Holdings Corporation's business trajectory between earnings reports.